Estudio de seguridad y salud para la construcción de una planta de molienda de clinker

El proyecto tiene por objeto establecer, en el marco de la Ley 31/1995, de 8 de noviembre, sobre prevención de riesgos laborales, y en su norma reglamentaria, el Real Decreto 1627/1997 de 24 de octubre, sobre disposiciones mínimas de seguridad y salud en las obras de construcción, la identificación y evaluación de riesgos de una planta industrial de molienda de clinker para fabricación de cemento, con objeto de determinar las medidas preventivas necesarias para garantizar las adecuadas condiciones de seguridad y salud de los trabajadores que intervengan en la construcción de la obra civil, y en los montajes eléctrico y mecánico. La metodología que se empleó para estimar los niveles de riesgo se basa en la conjunción de la probabilidad estimada y las consecuencias esperadas. Los resultados obtenidos a partir de los niveles de riesgo identificados demostraron que mediante la mejora de los controles existentes y la implantación de nuevas medidas de control, priorizando de forma que éstas siempre sean proporcionales al riesgo identificado y valorado, es posible garantizar los adecuados niveles de seguridad y salud durante la ejecución de la obra. ABSTRACT The main objective of this project is, in the frame of the Law 31/1995 of November 8th about prevention of labor risks and in its regulation norm, Royal Decree 1627/1997 of October 24th, about minimum dispositions of safety and health in the works of construction, the identification and evaluation of the risks involved in an industrial plant of grinding of clinker for cement manufacture in order to determine the preventive necessary measures to ensure the suitable conditions of safety and health of the workers who take part of civil works, and of electrical and mechanical erections. The methodology chosen to estimate the risk levels is based on the probability of happening together with the awaited consequences. The results obtained from the levels of risk identified demonstrated that by means of the improvement of the existing controls and the implementation of new control measures, determining priorities always proportionally to the identified and valued risk, it is possible to guarantee the suitable levels of safety and health during the execution of the works.

Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes

Objective: This study assessed the efficacy of a closed-loop (CL) system consisting of a predictive rule-based algorithm (pRBA) on achieving nocturnal and postprandial normoglycemia in patients with type 1 diabetes mellitus (T1DM). The algorithm is personalized for each patient’s data using two different strategies to control nocturnal and postprandial periods. Research Design and Methods: We performed a randomized crossover clinical study in which 10 T1DM patients treated with continuous subcutaneous insulin infusion (CSII) spent two nonconsecutive nights in the research facility: one with their usual CSII pattern (open-loop [OL]) and one controlled by the pRBA (CL). The CL period lasted from 10 p.m. to 10 a.m., including overnight control, and control of breakfast. Venous samples for blood glucose (BG) measurement were collected every 20 min. Results: Time spent in normoglycemia (BG, 3.9–8.0 mmol/L) during the nocturnal period (12 a.m.–8 a.m.), expressed as median (interquartile range), increased from 66.6% (8.3–75%) with OL to 95.8% (73–100%) using the CL algorithm (P<0.05). Median time in hypoglycemia (BG, <3.9 mmol/L) was reduced from 4.2% (0–21%) in the OL night to 0.0% (0.0–0.0%) in the CL night (P<0.05). Nine hypoglycemic events (<3.9 mmol/L) were recorded with OL compared with one using CL. The postprandial glycemic excursion was not lower when the CL system was used in comparison with conventional preprandial bolus: time in target (3.9–10.0 mmol/L) 58.3% (29.1–87.5%) versus 50.0% (50–100%). Conclusions: A highly precise personalized pRBA obtains nocturnal normoglycemia, without significant hypoglycemia, in T1DM patients. There appears to be no clear benefit of CL over prandial bolus on the postprandial glycemia